Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95666202 | 9566620 | 2 | F | 2000 | 20160809 | 20130930 | 20160829 | PER | US-AMGEN-USASP2012062982 | AMGEN | 61.00 | YR | A | F | Y | 58.50000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95666202 | 9566620 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, 2 TIMES/WK | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | ||||||
95666202 | 9566620 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, QWK | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
95666202 | 9566620 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | CAPSULE | ||||||||
95666202 | 9566620 | 4 | C | CELEBREX | CELECOXIB | 1 | 200 MG, UNK | 0 | 200 | MG | CAPSULE | ||||||||
95666202 | 9566620 | 5 | C | TYLENOL 8 HR | ACETAMINOPHEN | 1 | 650 MG | 0 | 650 | MG | |||||||||
95666202 | 9566620 | 6 | C | ASA EC | 2 | 81 MG, LOW DOSE EC | 0 | 81 | MG | TABLET | |||||||||
95666202 | 9566620 | 7 | C | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | 125 MUG, UNK | 0 | 125 | UG | TABLET | ||||||||
95666202 | 9566620 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
95666202 | 9566620 | 9 | C | CLARITIN | LORATADINE | 1 | 5 MG, UNK CHW | 0 | 5 | MG | |||||||||
95666202 | 9566620 | 10 | C | BENADRYL ALLERGY | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 25 MG, UNK ALG | 0 | 25 | MG | |||||||||
95666202 | 9566620 | 11 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
95666202 | 9566620 | 12 | C | CITRACAL PLUS | CALCIUMMAGNESIUMVITAMIN DINC | 1 | UNK | 0 | TABLET | ||||||||||
95666202 | 9566620 | 13 | C | COENZYME Q10 | UBIDECARENONE | 1 | 30 MG, UNK | 0 | 30 | MG | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
95666202 | 9566620 | 1 | Rheumatoid arthritis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
95666202 | 9566620 | Drug dose omission | |
95666202 | 9566620 | Joint swelling | |
95666202 | 9566620 | Off label use | |
95666202 | 9566620 | White blood cell count decreased | |
95666202 | 9566620 | White blood cell disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
95666202 | 9566620 | 1 | 1999 | 0 |